Cloning and characterization of peptidylprolyl isomerase B in the silkworm, Bombyx mori

African Journal of Biotechnology

Volumn 8, Issue 24, 2009, Pages 7116-7124

  Xia, Hengchuan ^a   Lv, Honggang ^a   Chen, Keping ^a   Yao, Qin ^a   Lv, Peng ^a   Li, Jun ^a   Chen, Huiqing ^a   Wang, Lin ^b  

^a JIANGSU UNIVERSITY   (China)

^b Beijing Entry Exit Inspection and Quarantine Bureau   (China)

Author keywords

Bioinformatics; Mass spectrometry; Prokaryotic expression; Subcellular localization; Transcription analysis

Indexed keywords

COMPLEMENTARY DNA; CYCLOPHILIN; PEPTIDYLPROLYL ISOMERASE; PEPTIDYLPROLYL ISOMERASE B; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; ENZYME ANALYSIS; EXON; FLUORESCENCE MICROSCOPY; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; SILKWORM;

BOMBYX MORI; BOMBYX MORI NPV; PROKARYOTA;

EID: 74549202789     PISSN: None     EISSN: 16845315     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Barik S (2006). Immunophilins: for the love of proteins. Cell Mol Life Sci. 63(24): 2889-900.
2. Denys A, Allain F, Carpentier M, Spik G (1998). Involvement of two classes of binding sites in the interactions of cyclophilin B with peripheral blood T-lymphocytes. Biochem. J. 336(3): 689-97.
3. Edvardsson A, Eshaghi S, Vener AV, Andersson B (2003). The major peptidyl-prolyl isomerase activity in thylakoid lumen of plant chloroplasts belongs to a novel cyclophilin TLP20. FEBS letters, 542 (1-3): 137-41.
4. Esnault S, Shen ZJ, Malter JS (2008). Pinning down signaling in the immune system: the role of the peptidyl-prolyl isomerase Pin1 in immune cell function. Crit. Rev. Immunol. 28(1): 45-60.
5. Fanghänel J, Fischer G (2004). Insights into the catalytic mechanism of peptidyl prolyl cis/trans isomerases. Front Biosci. 1(9): 3453-3478.
6. Yang F, Robotham JM, Nelson HB, Irsigler A, Kenworthy R, Tang H (2008). Cyclophilin A Is an Essential Cofactor for Hepatitis C Virus Infection and the Principal Mediator of Cyclosporine Resistance In Vitro. J. Virol. 82(11): 5269-5278.
7. Finn G, Lu KP (2008). Phosphorylation-specific prolyl isomerase Pin1 as a new diagnostic and therapeutic target for cancer. Curr. Cancer Drug Targets, 8(3): 223-229.
8. Franke EK, Yuan HEH, Luban J (1994). Specific incorporation of cyclophilin A into HIV-1 virions. Nature, 372: 359-362.
9. Galat A (2003). Peptidylprolyl cis/trans isomerases (immunophilins): biological diversity - targets - functions. Curr. Topp. Med. Chem. 3(12): 1315-47.
10. Göthel SF, Marahiel MA (1999). Peptidyl-prolyl cis-trans isomerases, a superfamily of ubiquitous folding catalysts. Cell Mol. Life Sci. 55(3): 423-436.
11. Isakov N (2008). A new twist to adaptor proteins contributes to regulation of lymphocyte cell signaling. Trends Immunol. 29(8):388-96.
12. Kang CB, Hong Y, Dhe-Paganon S, Yoon HS (2008). FKBP family proteins: immunophilins with versatile biological functions. Neurosignals, 16(4): 318-25.
13. Koser PL, Sylvester D, Livi GP, Bergsma DJ (1990). A second cyclophilin-related gene in Saccharomyces cerevisiae. Nucleic Acids Res. 18(6): p. 1643.
14. Lippens G, Landrieu I, Smet C (2007). Molecular mechanisms of the phospho-dependent prolyl cis/trans isomerase Pin1. FEBS J. 274(20): 5211-5222.
15. Lu KP, Finn G, Lee TH, Nicholson LK (2007a). Prolyl cis-trans isomerization as a molecular timer. Nat. Chem. Biol. 3(10): 619-629.
16. Lu KP, Zhou XZ (2007b). The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease. Nat. Rev. Mol. Cell Biol. 8(11): 904-916.
17. Luban J, Bossolt KL, Franke EK, Kalpana GV, Goff SP (1993). Human immunodeficiency virus type I gag protein binds to cyclophilin A and B. Cell. 73: 1067-1078.
18. Mariller C, Allain F, Kouach M, Spik G (1996). Evidence that human milk isolated cyclophilin B corresponds to a truncated form. Biochimica et Biophysica Acta. 1293(1): 31-38.
19. Miele R, Borro M, Mangoni ML, Simmaco M, Barra D (2003). A peptidylprolyl cis/trans isomerase from Xenopus laevis skin: cloning, biochemical characterization and putative role in the secretion. Peptides, 24(11): 1713-1721.
20. Mitra D, Mukherjee S, Das AK (2006). Cyclosporin A binding to Mycobacterium tuberculosis peptidyl-prolyl cis-trans isomerase A--investigation by CD, FTIR and fluorescence spectroscopy. FEBS letters, 580(30): 6846-6860.
21. Page AP, Winter AD (1999). Expression pattern and functional significance of a divergent nematode cyclophilin in Caenorhabditis elegans. Mol. Biochem. Parasitol. 99(2): 301-306.
22. Pelle R, McOdimba F, Chuma F, Wasawo D, Pearson T W, Murphy N B (2002). The African trypanosome cyclophilin A homologue contains unusual conserved central and N-terminal domains and is developmentally regulated. Gene, 290(1-2): 181-191.
23. Rahfeld JU, Schierhorn A, Mann K, Fischer G (1994). A novel peptidylprolyl cis/trans isomerase from Escherichia coli. FEBS letters, 343(1): 65-69.
24. Rippmann JF, Hobbie S, Daiber C, Guilliard B, Bauer M, Birk J, Nar H, Garin-chesa P, Rettig WJ, Schnapp A (2000). Phosphorylationdependent proline isomerization catalyzed by Pin 1 is essential for tumor cell survival and entry into mitosis. Cell Growth Differ. 11: 409-416.
25. Saphire AC, Bobardt MD, Gallay PA (2000). Human immunodeficiency virus type 1 hijacks host cyclophilin A for its attachment to target cells. Immunol. Res. 21(2-3): 211-217.
26. Setkowicz Z, Ciarach M (2007). Neuroprotectants FK-506 and cyclosporin A ameliorate the course of pilocarpine-induced seizures. Epilepsy Res. 73(2): 151-155.
27. Shaw PE (2002). Peptidyl-prolyl isomerases: a new twist to transcription. EMBO Rep. 3(6): 521-526.
28. Takaki Y, Muta T, Iwanaga S (1997). A peptidyl-prolyl cis/transisomerase (cyclophilin G) in regulated secretory granules. J. Biol. Chem. 272(45): 28615-21.
29. Tang BL, Liou YC (2007). Novel modulators of amyloid-beta precursor protein processing. J. Neurochem.100(2): 314-323.
30. Tryon RC, White SD, Bannasch DL (2007). Homozygosity mapping approach identifies a missense mutation in equine cyclophilin B (PPIB) associated with HERDA in the American Quarter Horse. Genomics, 90(1): 93-102.
31. Uchida T, Takamiya M, Takahashi M, Miyashita H, Ikeda H, Terada T, Matsuo Y, Shirouzu M, Yokoyama S, Fujimori F, Hunter T (2003). Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation. Chem. Biol. 10(1): 15-24.
32. Waldmeier PC, Zimmermann K, Qian T, Tintelnot-Blomley M, Lemasters JJ (2003). Cyclophilin D as a drug target. Curr. Med. Chem. 10(16): 1485-506.
33. Wang T, Yun CH, Gu SY, Chang WR, Liang DC (2005). 1.88 A crystal structure of the C domain of hCyP33: a novel domain of peptidylprolyl cis-trans isomerase. Biochem. Biophys. Res. Commun. 333(3): 845-849.
34. Watashia K, Ishiia N, Hijikata M, Inoue D, Murata T, Miyanari Y, Shimotohno K (2005). Cyclophilin B Is a Functional Regulator of Hepatitis C Virus RNA Polymerase. Mol. Cell. 19(1): 111-122.
35. Wulf G, Finn G, Suizu F, Lu KP (2005). Phosphorylation-specific prolyl isomerization: is there an underlying theme? Nat. Cell Biol. 7(5): 435-41.
36. Liu X, Chen K, Cai K, Yao Q (2008). Determination of protein composition and host-derived proteins of Bombyx mori nucleopolyhedrovirus by two-dimensional electrophoresis and mass spectrometry. Intervirology, 51: 369-376,
37. Xu YX, Manley JL (2007). New insights into mitotic chromosome condensation: a role for the prolyl isomerase Pin1. Cell Cycle, 6(23): 2896-901.
38. Yao Q, Li M, Yang H, Chai H, Fisher W, Chen C (2005). Roles of cyclophilins in cancers and other organ systems. World J. Surg. 29 (3): 276-280.
39. Yeh HY, KlesiusPH (2008). Channel catfish, Ictalurus punctatus, cyclophilin A and B cDNA characterization and expression analysis. Vet Immunol Immunopathol. 121(3-4): 370-377.